BackNatera Overview
Natera Inc

Natera Target Price

See Natera's analyst price targets ($330) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$414.52

Average Target Price

$329.4120.5% downside

22 analysts in the last 4 months

High: $460 | Low: $245

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-25RBC Capital$46011% upsideOpen
2026-09-09UBS$4354.9% upsideOpen
2026-09-08Redburn Partners$3857.1% downsideOpen
2026-08-12Stephens$35015.6% downsideOpen
2026-08-12Guggenheim$36013.2% downsideOpen
2026-08-10Morgan Stanley$35514.4% downsideOpen
2026-08-07RBC Capital$35015.6% downsideOpen
2026-08-07Robert W. BairdCatherine Ramsey Schulte$34816% downsideOpen
2026-08-07Canaccord GenuityKyle Mikson$3759.5% downsideOpen
2026-08-07Wells Fargo$28431.5% downsideOpen
2026-08-07BTIG$32022.8% downsideOpen
2026-08-07Leerink Partners$33020.4% downsideOpen
2026-08-07Barclays$34018% downsideOpen
2026-07-14Canaccord Genuity$33020.4% downsideOpen
2026-07-09Morgan Stanley$31025.2% downsideOpen
2026-07-06Evercore ISI$30027.6% downsideOpen
2026-06-29GuggenheimSubbu Nambi$29030% downsideOpen
2026-06-24BTIG$27533.7% downsideOpen
2026-06-24UBS$26037.3% downsideOpen
2026-06-23BTIG$27034.9% downsideOpen
2026-06-11RBC CapitalDan Leonard$27533.7% downsideOpen
2026-06-05Goldman SachsEvie Koslosky$24540.9% downsideOpen
2026-05-12Piper Sandler$24939.9% downsideOpen
2026-05-08Robert W. Baird$26536.1% downsideOpen
2026-05-08Evercore ISI$27034.9% downsideOpen
2026-05-08Wells FargoBrandon Couillard$22046.9% downsideOpen
2026-01-05Guggenheim$27034.9% downsideOpen
2025-12-22Canaccord Genuity$28531.2% downsideOpen
2025-12-15Wells Fargo$20550.5% downsideOpen
2025-12-15Barclays$27034.9% downsideOpen
2025-12-01Morgan Stanley$26536.1% downsideOpen
2025-11-18UBS$28032.5% downsideOpen
2025-10-27BNP ParibasNavann Ty$17258.5% downsideOpen
2025-09-22Wells FargoBrandon Couillard$17557.8% downsideOpen
2025-09-02RBC CapitalConor McNamara$26835.3% downsideOpen
2025-08-10Morgan StanleyPatrick Wood$19553% downsideOpen
2025-02-28Canaccord Genuity$19553% downsideOpen
2024-11-13JefferiesTycho Peterson$18256.1% downsideOpen
2024-11-13Robert W. BairdCatherine Ramsey Schulte$16061.4% downsideOpen
2024-10-29Canaccord GenuityKyle Mikson$15063.8% downsideOpen
2024-09-13Piper SandlerDave Westenberg$15063.8% downsideOpen
2024-08-27Canaccord GenuityKyle Mikson$14565% downsideOpen
2024-08-13Morgan StanleyTejas Savant$13268.2% downsideOpen
2024-08-09Robert W. BairdCatherine Ramsey Schulte$12071.1% downsideOpen
2024-06-25Wolfe ResearchDoug Schenkel$13567.4% downsideOpen
2024-06-03JefferiesTycho Peterson$14265.7% downsideOpen
2024-05-14Piper SandlerDavid Westenberg$12071.1% downsideOpen
2024-05-13BTIGMark Massaro$12569.8% downsideOpen
2024-05-10Robert W. BairdCatherine Ramsey Schulte$11771.8% downsideOpen
2024-04-05BernsteinEve Burstein$12071.1% downsideOpen

Natera (NTRA) FAQ

Natera (NTRA) currently reports a target price of $330. Use the charts on this page to explore Natera's target price history and peer comparisons.

Analysts' average 12-month price target for Natera is $330, about 20.5% downside from the current share price of $414.52. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $330, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Natera, and consider following NTRA for alerts when major investors trade the stock.

Natera is classified in the Healthcare sector. On target price, it currently shows $330. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NTRA with unrelated industries.